Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives

doi:10.4251/wjgo.v17.i11.110735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

(44)

(45)

(0)

(1)

(963)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Nov 15, 2025; 17(11): 110735
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110735

Full Size Figure Download Figure

Figure 1 Schematic illustration of locoregional therapies for hepatocellular carcinoma[29]. CT: Computed tomography. Citation: Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29: 413-424. Copyright© The Authors 2023. Published by Baishideng Publishing Group.

Citation: Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735
URL: https://www.wjgnet.com/1948-5204/full/v17/i11/110735.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.110735

Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735 [PMID: 41281491 DOI: 10.4251/wjgo.v17.i11.110735]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.